GD2-CAR T Cell Therapy for H3K27M+ Diffuse Intrinsic Pontine Glioma: A Phase I Clinical Trial and Mechanistic InsightsCongfa Jiang1,2,*,#, Hening Xu3,#, Jianqiao Shentu3, Shiwei Duan3,*Department of Hematology, Ningbo Fourth Hospital, Ningbo 315700, Zhejiang, ChinaXiangshan First People’s Hospital Medical and Health Group, Ningbo 315700, Zhejiang, ChinaDepartment of Clinical Medicine, School of Medicine, Hangzhou City University, Hangzhou 310015, Zhejiang, China.#: These authors contributed equally to this work.*: Correspondence should be addressed to Drs. Congfa Jiang (jiangcongfa01@163.com) and Shiwei Duan (duansw@hzcu.edu.cn).Keywords: GD2-CAR T cell therapy, H3K27M mutation, diffuse intrinsic pontine glioma, solid tumors, cytokine release syndrom